Hepatitis C among drug users in Europe. Epidemiology, treatment and prevention
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Eará dahkkit: | |
| Materiálatiipa: | Monograph |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Lisboa
European Monitoring Centre for Drugs and Drug Addiction
2016
|
| Ráidu: | Insights
23 |
| Fáttát: | |
| Liŋkkat: | Servidor Enlace web |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid: Hepatitis C among drug users in Europe. Epidemiology, treatment and prevention
- Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
- Increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process
- Evidence for the effectiveness of interventions to prevent infections: Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour among people who inject drugs
- Eliminating Hepatitis C in Europe: A report on policy implementation for people who inject drugs
- Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe
- Plan Estratégico para el Abordaje de la Hepatitis C en el Sistema Nacional de Salud